Globe Life's results for Q3 2026 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-21. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $1,596 million (+5.5% vs a year earlier) |
| Diluted EPS (GAAP) | $4.62 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $4.84 |
| Full-year guidance | Stated (no change given) |
Guidance
Adjusted 2026 net operating EPS guidance to $15.35–$15.65, citing United American claims items; estimates 2027 at $16.10–$17.10.
Why this label: 2026 EPS guidance 'adjusted' to $15.35-15.65 with no prior range or direction word; buyback raise is not core, so 'mixed' unsupported. 2027 estimate not called initial.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| net operating income per diluted share | FY2026 | $15.35–$15.65 | not stated |
| net operating income per diluted share | FY2027 | $16.10–$17.10 | not stated |
| share repurchases | FY2026 | $725–$775 million | $670–$700 million |
From the release
Revenue: "Total revenue · 1,595,937 · 1,512,988"
Earnings per share: "net income was $4.62 per diluted common share, compared with $4.73 per diluted common share for the year-ago quarter. Net operating income was $4.84 per diluted common share, compared with $4.81 per diluted common share for the year-ago quarter."
net operating income per diluted share: "The Company adjusted full-year 2026 earnings guidance to a range of $15.35 to $15.65"
net operating income per diluted share: "For the year ending December 31, 2027, we estimate that net operating income per share will be in the range of $16.10 to $17.10, an increase of 7.1% at the midpoint."
share repurchases: "The Company expects to spend $725 million to $775 million to repurchase common stock for the full year 2026, compared to the previous guidance of $670 million to $700 million."
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: 2026 EPS guidance adjusted to $15.35–$15.65 on United American claims; 2027 guided $16.10–$17.10.
Source
Globe Life earnings release (SEC filing), accession 0000320335-26-000224, filed 2026-10-21.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.